对一个评分系统的评估,以预测异胎妊娠中单剂量甲状腺素治疗的成功率
Ali Selcuk Yeniocak1, Can Tercan2, Emrah Dagdeviren2
1Department of Obstetrics and Gynecology, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey. a.s.yeniocak@hotmail.com.
Archives of gynecology and obstetrics
|March 15, 2024
概括
一个新的评分系统有效地预测子宫外妊娠的甲状腺治疗成功. 客观参数确定了关键因素,改善了治疗结果预测和患者护理.
科学领域:
- 生殖内分泌学 生殖内分泌学
- 妇科瘤学 妇科瘤学
- 在产科中使用医学成像.
背景情况:
- 宫外怀孕带来很大的风险,需要准确预测治疗结果.
- 甲托雷克萨特治疗是一种常见的治疗方法,但预测其成功可能具有挑战性.
研究的目的:
- 评估一种新的评分系统,用于预测接受甲醇的异胎妊娠患者的治疗结果.
- 评估客观参数的可靠性和预测准确性,以确定甲状腺治疗的成功.
主要方法:
- 一个回顾性队列研究,涉及151名接受甲铁酸治疗的异胎妊娠患者.
- 分析参数,包括附质量大小,腹膜液,黄囊,子宫内膜厚度和B-hCG水平.
- 评估一个新开发的客观评分系统的预测性能.
主要成果:
- 在几个客观参数 (例如,副质量大小>3.5厘米,腹膜液,黄囊,子宫内膜厚度>10毫米,初始B-hCG) 和甲状腺素治疗结果 (p < 0.001) 之间发现了显著的关联.
- 这种新型评分系统显示出有前途的预测能力,在不同的截止点具有很高的灵敏度 (例如,在截止点3.50时94.0%的灵敏度).
结论:
- 客观参数,特别是在开发的评分系统中,与子宫外妊娠中甲状腺素治疗结果密切相关.
- 拟议的评分模型有可能显著帮助临床决策,预后和患者护理.
更多相关视频
09:04Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
9.7K
05:16Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
Published on: August 4, 2021
3.4K
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...